miR‐33 in cardiometabolic diseases: lessons learned from novel animal models and approaches
Abstract miRNAs have emerged as critical regulators of nearly all biologic processes and important therapeutic targets for numerous diseases. However, despite the tremendous progress that has been made in this field, many misconceptions remain among much of the broader scientific community about the...
Saved in:
| Main Authors: | Nathan L Price, Leigh Goedeke, Yajaira Suárez, Carlos Fernández‐Hernando |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2021-05-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.202012606 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma
by: Mst Nasrin Akhtar, et al.
Published: (2025-06-01) -
Macrophage deficiency of miR‐21 promotes apoptosis, plaque necrosis, and vascular inflammation during atherogenesis
by: Alberto Canfrán‐Duque, et al.
Published: (2017-07-01) -
A miRNA Signature for Non-Invasive Colorectal Cancer Diagnosis in Morocco: miR-21, miR-29a and miR-92a
by: Sofia Fathi, et al.
Published: (2025-03-01) -
Differential circulating miRNA profiles identified miR-423-5p, miR-93-5p, and miR-4532 as potential biomarkers for cholangiocarcinoma diagnosis
by: Kittiya Supradit, et al.
Published: (2024-12-01) -
Estimation of miRNA-21, miRNA-422, miRNA‐142-3p, and miR-181c Gene Expression as Potential Biomarkers of Osteoporosis in Premenopausal Women
by: Nahidah kzar madhloom, et al.
Published: (2025-06-01)